These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30713808)

  • 1. Pomalidomide increases immune surface marker expression and immune recognition of oncovirus-infected cells.
    Davis DA; Shrestha P; Aisabor AI; Stream A; Galli V; Pise-Masison CA; Tagawa T; Ziegelbauer JM; Franchini G; Yarchoan R
    Oncoimmunology; 2019; 8(2):e1546544. PubMed ID: 30713808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient Viral Activation in Human T Cell Leukemia Virus Type 1-Infected Macaques Treated With Pomalidomide.
    Gutowska A; McKinnon K; Sarkis S; Doster MN; Bissa M; Moles R; Stamos JD; Rahman MA; Washington-Parks R; Davis D; Yarchoan R; Franchini G; Pise-Masison CA
    Front Med (Lausanne); 2022; 9():897264. PubMed ID: 35602479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restoration of immune surface molecules in Kaposi sarcoma-associated herpes virus infected cells by lenalidomide and pomalidomide.
    Davis DA; Mishra S; Anagho HA; Aisabor AI; Shrestha P; Wang V; Takamatsu Y; Maeda K; Mitsuya H; Zeldis JB; Yarchoan R
    Oncotarget; 2017 Aug; 8(31):50342-50358. PubMed ID: 28881567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CDK4/6 inhibitors sensitize gammaherpesvirus-infected tumor cells to T-cell killing by enhancing expression of immune surface molecules.
    Wu Y; Shrestha P; Heape NM; Yarchoan R
    J Transl Med; 2022 May; 20(1):217. PubMed ID: 35562811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pomalidomide restores immune recognition of primary effusion lymphoma through upregulation of ICAM-1 and B7-2.
    Shrestha P; Davis DA; Jaeger HK; Stream A; Aisabor AI; Yarchoan R
    PLoS Pathog; 2021 Jan; 17(1):e1009091. PubMed ID: 33411730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism and therapeutic implications of pomalidomide-induced immune surface marker upregulation in EBV-positive lymphomas.
    Jaeger HK; Davis DA; Nair A; Shrestha P; Stream A; Yaparla A; Yarchoan R
    Sci Rep; 2023 Jul; 13(1):11596. PubMed ID: 37463943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.
    Banerjee P; Feuer G; Barker E
    J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lytic cycle of Epstein-Barr virus is associated with decreased expression of cell surface major histocompatibility complex class I and class II molecules.
    Keating S; Prince S; Jones M; Rowe M
    J Virol; 2002 Aug; 76(16):8179-88. PubMed ID: 12134023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus encoded interleukin-10 inhibits HLA-class I, ICAM-1, and B7 expression on human monocytes: implications for immune evasion by EBV.
    Salek-Ardakani S; Arrand JR; Mackett M
    Virology; 2002 Dec; 304(2):342-51. PubMed ID: 12504574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of B7 molecules by the Epstein-Barr virus enhances susceptibility to lysis by a human NK-like cell line.
    Montel AH; Morse PA; Brahmi Z
    Cell Immunol; 1995 Jan; 160(1):104-14. PubMed ID: 7531116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus-infected B cells of males with the X-linked lymphoproliferative syndrome stimulate and are susceptible to T-cell-mediated lysis.
    Jäger M; Benninger-Döring G; Prang N; Sylla BS; Laumbacher B; Wank R; Wolf H; Schwarzmann F
    Int J Cancer; 1998 May; 76(5):694-701. PubMed ID: 9610728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus permissively infects human syncytiotrophoblasts in vitro and induces replication of human T cell leukemia-lymphoma virus type I in dually infected cells.
    Tóth FD; Aboagye-Mathiesen G; Nemes J; Liu X; Andirkó I; Hager H; Zdravkovic M; Szabó J; Kiss J; Aranyosi J; Ebbesen P
    Virology; 1997 Mar; 229(2):400-14. PubMed ID: 9126252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of IL-10 secretion and enhanced antigen-presenting abilities following HTLV-I infection of T cells.
    Scholz C; Hafler DA; Höllsberg P
    J Neurosci Res; 1996 Sep; 45(6):786-94. PubMed ID: 8892090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of the Lytic Cycle Sensitizes Epstein-Barr Virus-Infected B Cells to NK Cell Killing That Is Counteracted by Virus-Mediated NK Cell Evasion Mechanisms in the Late Lytic Cycle.
    Williams LR; Quinn LL; Rowe M; Zuo J
    J Virol; 2016 Jan; 90(2):947-58. PubMed ID: 26537677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA Class I Downregulation by HIV-1 Variants from Subtype C Transmission Pairs.
    Ende Z; Deymier MJ; Claiborne DT; Prince JL; Mónaco DC; Kilembe W; Allen SA; Hunter E
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of human herpes virus type 8-associated diseases by NK cells.
    Sirianni MC; Campagna M; Scaramuzzi D; Carbonari M; Toschi E; Bacigalupo I; Monini P; Ensoli B
    Ann N Y Acad Sci; 2007 Jan; 1096():37-43. PubMed ID: 17405914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of major histocompatibility complex class I downregulation with resistance of human T-cell leukemia virus type 1-infected T cells to cytotoxic T-lymphocyte killing in a rat model.
    Ohashi T; Hanabuchi S; Suzuki R; Kato H; Masuda T; Kannagi M
    J Virol; 2002 Jul; 76(14):7010-9. PubMed ID: 12072501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphotropic viruses, Epstein-Barr virus (EBV) and human T-cell lymphotropic virus-I (HTLV-I)/adult T-cell leukemia virus (ATLV), and HTLV-III/human immune deficiency virus (HIV) as etiological agents of malignant lymphoma and immune deficiency.
    Purtilo DT
    AIDS Res; 1986 Dec; 2 Suppl 1():S1-6. PubMed ID: 2881552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syncytium-inhibiting monoclonal antibodies produced against human T-cell lymphotropic virus type 1-infected cells recognize class II major histocompatibility complex molecules and block by protein crowding.
    Hildreth JE
    J Virol; 1998 Dec; 72(12):9544-52. PubMed ID: 9811687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The innate and T-cell mediated immune response during acute and chronic gammaherpesvirus infection.
    Rex V; Zargari R; Stempel M; Halle S; Brinkmann MM
    Front Cell Infect Microbiol; 2023; 13():1146381. PubMed ID: 37065193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.